Andrew J. Schwab's Net Worth

$0

Estimate Recalculated Nov 11, 2024 08:51AM EST

Who is Andrew J. Schwab?

Andrew J. Schwab does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Enliven Therapeutics, Inc., Skye Bioscience, Inc., , Flexion Therapeutics Inc, Crinetics Pharmaceuticals, Inc., Entrada Therapeutics, Inc., Vor Biopharma Inc., Pear Therapeutics, Inc., IDEAYA Biosciences, Inc., Rallybio Corp, ARVINAS INC., 5:01 Acquisition Corp., IMPEL NEUROPHARMA INC, Cidara Therapeutics, Inc., VIVEVE MEDICAL, INC., scPharmaceuticals Inc., Cabaletta Bio, Inc., Akouos, Inc., Homology Medicines, Inc., Aprea Therapeutics, Inc., Audentes Therapeutics, Inc., PHASERX, INC., EPIRUS Biopharmaceuticals, Inc., and Artiva Biotherapeutics, Inc..

SEC CIK

Andrew J. Schwab's CIK is 0001598549

Past Insider Trading and Trends

2023 was Andrew J. Schwab's most active year for acquiring shares with 3 total transactions. Andrew J. Schwab's most active month to acquire stocks was the month of January. 2023 saw Andrew J. Schwab paying a total of $0.00 for 1,514,369 shares, this is the most they've acquired in one year.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Enliven Therapeutics, Inc. (ELVN) Snapshot price: $21.44

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-17.70%
-825.00K
$14.90
-$12,292,500.00
3.84M
Feb 14
Form 4
-9.69%
-500.00K
$15.00
-$7,500,000.00
4.66M
Jan 31
Form 4
-3.69%
-197.50K
$15.00
-$2,962,500.00
5.16M
Sep 26
Form 4
-7.59%
-440.00K
$16.00
-$7,040,000.00
5.36M
Aug 24
Form 4
—
0
—
—
0
Feb 23
Form 4
∞
5.8M
—
—
5.8M
Feb 23
Form 3
—
0
—
—
0
No matching records found

Skye Bioscience, Inc. (SKYE) Snapshot price: $5.84

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Oct 28
Form 4
-2.62%
-266.34K
$6.57
-$1,750,352.22
9.91M
Sep 11 - Sep 13
Form 4
+5.66%
450K
$10.00
$4,500,000.00
8.39M
Mar 13
Form 4
—
0
—
—
0
Feb 29
Form 4
+190.18%
5.21M
$2.31
$12,026,030.94
7.94M
Jan 31
Form 4
—
0
—
—
0
Nov 6
Form 4
—
0
—
—
0
Aug 25
Form 4
∞
1.13B
$0.01
$7,048,922.90
1.13B
Aug 18
Form 3
—
0
—
—
0
No matching records found

No price found

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-4.94M
—
—
0
Feb 24
Form 4
+15.62%
600K
$30.00
$18,000,000.00
4.44M
Aug 15
Form 4
∞
4.34M
$16.00
—
4.34M
Jan 11
Form 3
—
0
—
—
0
No matching records found

Flexion Therapeutics Inc No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Mar 3
Form 4
+12,194.30%
1.5M
—
—
1.51M
Feb 18
Form 3
—
0
—
—
0
No matching records found

Crinetics Pharmaceuticals, Inc. (CRNX) Snapshot price: $50.39

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-9.57%
-250.00K
$22.20
-$5,550,000.00
2.36M
Jun 21
Form 4
-5.60%
-154.84K
$24.25
-$3,754,954.14
2.61M
Mar 18
Form 4
-14.35%
-464.83K
—
—
2.77M
Feb 20
Form 4
-7.49%
-262.15K
$21.88
-$5,734,596.87
3.24M
Jan 22
Form 4
+103.40%
3.5M
$17.00
$1,955,000.00
6.88M
Jul 20
Form 3
—
0
—
—
0
No matching records found